A direct role of P2Y12 in ovarian cancer cells was ruled out since Western blot analysis did not detect the receptor at the protein levels, and knocking down P2Y12 by siRNA or CRISPR-Cas9 techniques did not affect the cancer cell proliferation either in vitro or in vivo (Cho et al., 2017). This evidence concerns the gene P2RY12 and ovarian cancer.